From: Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies
PARP | Enzymatic activity | Biological function | References |
---|---|---|---|
PARP1 | Poly- | DDR | [1] |
PARP2 | Poly- | DDR | [1] |
PARP3 | Mono- | DDR and mitosis regulation | [9] |
PARP4 | Poly- | Antiviral response | [10] |
TNSK1 PARP5a | Poly- | DDR, telomere maintenance and mitosis regulation | [11] |
TNSK2 PARP5b | Poly- | DDR, telomere maintenance and mitosis regulation | [12] |
PARP6 | Mono- | Cell cycle progression | [13] |
PARP7 | Mono- | Cell–cell adhesion, inhibition of type I interferon response and gene regulation | [14] |
PARP8 | Mono- | Unknown | – |
PARP9 | Inactive | DDR, gene transcription and antiviral response | [15] |
PARP10 | Mono- | binding protein and an inhibitor of MYC with inhibitory potential also on the NF-κB signaling pathway | |
PARP11 | Mono- | Role in nuclear envelope biology | [17] |
PARP12 | Mono- | Regulation of stress granule assembly, microRNA activity and antiviral response | |
PARP13 | Inactive | Regulation of microRNA activity | [20] |
PARP14 | Mono- | Survival, cell migration, assembly of stress granules, transcription during inflammation processes, DDR and antiviral response | |
PARP15 | Mono- | Regulation of stress granule and antiviral response | |
PARP16 | Mono- | Regulation of unfolded protein response |